You are here

  • Home
  • Archive
  • Volume 74, Issue Suppl 1
  • A8.16 The cholinergic anti-inflammatory pathway does not influence sialadenitis or diabetes in the non-obese diabetic mouse model of SjÖgren’s syndrome

Article info

Article menu
Download PDFPDF
8. Targets and therapies
A8.16 The cholinergic anti-inflammatory pathway does not influence sialadenitis or diabetes in the non-obese diabetic mouse model of SjÖgren’s syndrome

Authors

Citation

Koopman F, Roescher N, Vosters J, et al
A8.16 The cholinergic anti-inflammatory pathway does not influence sialadenitis or diabetes in the non-obese diabetic mouse model of SjÖgren’s syndrome
Annals of the Rheumatic Diseases 2015;74:A87-A88.

Publication history

  • First published February 13, 2015.
Online issue publication 
October 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2015, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions